Tiny study checks blood pressure drug in kids
NCT ID NCT05107960
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at how safe and effective the blood pressure drug azilsartan is for children aged 6 to 16 with high blood pressure. Only 5 children took part, and doctors monitored them for side effects and blood pressure changes for up to 12 months. The goal was to gather real-world safety data, not to compare with other treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- azilsartan (Azilva tablets or granules)
- What this could lead to
- If results are positive, it could confirm that azilsartan is a safe and effective option for managing high blood pressure in children.
- What could go wrong
- This was a very small study (only 5 children) with no comparison group, so findings may not apply broadly. Side effects are still possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Takeda selected site
Tokyo, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a few short nights of sleep tip the scales toward high blood pressure?
- Chatbot could put blood pressure control in Patients' hands
- Can a 5-Step chat help tame high blood pressure?
- Can artery scans reveal hidden damage from high blood pressure?
- CRISPR injection could rewrite the future of blood pressure control
- Text messages and nurses: a new strategy to tackle hypertension in tanzania?